Capital Planning Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Capital Planning Advisors's BMY Position: Q1 2019 in Review
Capital Planning Advisors sold out of Bristol-Myers Squibb (BMY) in Q1 2019, closing a stake of 6,292 shares — an estimated $327K sold.
Capital Planning Advisors first reported a position in BMY in Q4 2014 and held it in 17 quarters. The position peaked at $3.66M in Q4 2015. 1,813 funds tracked by Wall St. Rank hold BMY as of Q1 2019.
- Capital Planning Advisors reported no remaining Bristol-Myers Squibb position as of Q1 2019 after selling out during the quarter.
- Capital Planning Advisors sold 6,292 Bristol-Myers Squibb shares in Q1 2019, an estimated $327K.
- Capital Planning Advisors first reported a position in Bristol-Myers Squibb in Q4 2014 and held it in 17 quarters.
- Capital Planning Advisors's Bristol-Myers Squibb position peaked at $3.66M in Q4 2015.
- 1,813 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2019.
Based on Capital Planning Advisors's 13F filing for Q1 2019, filed 14 May 2019.